Production of large populations of hematopoietic stem cells (hscs) in microgravity to treat serious medical conditions including blood cancers (leukemias, lymphomas, multiple myeloma), fatal blood…

Active Awarded Last action

Contract number
80JSC022F0146
Awardee
Awarding agency
Obligated
$3,318,354

Award facts

Contract value 100% obligated
$3,318,354.00 Current and potential, with all options
Completion date 93% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Basic Research
Pricing
Firm Fixed Price
Place of performance
Boulder, CO 80309, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 $183,354
Funding Only Action P00011 $285,000
Other Administrative Action P00010 $0
Supplemental Agreement for work within scope P00008 $0
Supplemental Agreement for work within scope P00009 $285,000
Funding Only Action P00007 $570,000
Funding Only Action P00006 -$855,000
Funding Only Action P00005 $855,000
Funding Only Action P00004 $570,000
Funding Only Action P00003 $285,000
Funding Only Action P00002 $285,000
Funding Only Action P00001 $285,000
Original award $570,000
Show all 13

About this award

NASA Johnson Space Center awarded The Regents of the University of Colorado a $3.32 million firm fixed-price delivery order on June 6, 2022, to support the production of large populations of hematopoietic stem cells (HSCs) in microgravity for treating serious medical conditions including blood cancers, fatal blood disorders, and severe immune diseases. This delivery order falls under a larger indefinite delivery vehicle with NASA Johnson Space Center focused on space life science research platforms and in-space manufacturing capabilities. The work, to be performed in Boulder, Colorado, with an ultimate completion date of February 20, 2027, represents a non-set-aside competitive award with no small business designation applied. The University of Colorado will leverage its established research capabilities and partnerships to advance this critical biomedical research initiative supporting NASA's life sciences objectives.

The prime contractor has engaged two major subcontractors to execute the project scope. The Regents of the University of Colorado-Denver (operating as ClinImmune Labs) will isolate, purify, and characterize clinical-grade CD34+ stem cells and gene-edited cells, conducting preflight validation and postflight analysis using flow cytometry and functional assays. Mayo Clinic Jacksonville, through Dr. Abba Zubair's team at the Medical Director of Transfusion Medicine and Stem Therapy Laboratory, will generate and analyze HSCs for the project, conduct all preflight validation studies, manage postflight experiments, and prepare scientific manuscripts for peer-reviewed publication. Together, these institutions will develop and validate specialized bioreactor technology for deployment on commercial space stations to expand cord blood and mobilized peripheral blood HSCs collected on Earth, with the ultimate goal of producing cryopreserved stem cell transplant units for clinical use in treating patients worldwide.

Description

Production of large populations of hematopoietic stem cells (hscs) in microgravity to treat serious medical conditions including blood cancers (leukemias, lymphomas, multiple myeloma), fatal blood disorders, and severe immune diseases.

Subawards

Subcontractor Amount Awarded
Mayo Clinic Jacksonville (A Nonprofit Corporation) PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $68,151
The Regents Of The University Of Colorado PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $54,119
Mayo Clinic Jacksonville (A Nonprofit Corporation) PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $90,000
The Regents Of The University Of Colorado PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $90,000
Mayo Clinic Jacksonville (A Nonprofit Corporation) PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $250,000
The Regents Of The University Of Colorado PRODUCTION OF LARGE POPULATIONS OF HEMATOPOIETIC STEM CELLS (HSCS) IN MICROGRAVITY TO TREAT SERIOUS MEDICAL CONDITIONS INCLUDING BLOOD CANCERS (LEUKEMIAS,… $253,500

Quick answers

Who was awarded contract 80JSC022F0146?

80JSC022F0146 was awarded to The Regents Of The University Of Colorado by Johnson Space Center (National Aeronautics and Space Administration) on June 6, 2022.

How much is contract 80JSC022F0146 worth?

The government has obligated $3,318,354 on 80JSC022F0146.

Is contract 80JSC022F0146 an order under another contract?

Yes. 80JSC022F0146 is a delivery order under 80JSC019D0026, an indefinite delivery contract.

Was contract 80JSC022F0146 competed?

The extent of competition for 80JSC022F0146 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award